Johnson & Johnson

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.

< Prev | | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | .... 34 Next >

New One-Year Phase 3 Study Results Show Anti-Tnf SIMPONI® Maintained Clinical Response In Treatment Of Moderately To Severely Active Ulcerative Colitis

October 22, 2012

Crohn’s Disease Patients Refractory To Tumor Necrosis Factor Inhibitors Showed Improvement In Disease With STELARA® Treatment

October 18, 2012

Cordis Corporation Announces One-Year Results from the STROLL Trial

October 10, 2012

First Results from Phase 3 CANVAS Trial Show Canagliflozin as Add-on Therapy to Insulin Lowered Blood Sugar Levels in Patients with Type 2 Diabetes at an Elevated Risk for Cardiovascular Disease

October 02, 2012

Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases

October 02, 2012

Janssen Presents Sustainable Health Care Programs at CleanMed Europe Conference, Malmo, Sweden

October 01, 2012

< Prev | | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | .... 34 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.